Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBoston Scientific Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 17 | $0.77 | $0.85 | $0.79 |
| Q2 2026 | 17 | $0.82 | $0.85 | $0.83 |
| Q3 2026 | 16 | $0.84 | $0.86 | $0.85 |
| Q4 2026 | 14 | $0.89 | $0.92 | $0.90 |
| Q1 2027 | 10 | $0.87 | $0.90 | $0.88 |
| Q2 2027 | 7 | $0.92 | $0.95 | $0.94 |
| Q3 2027 | 7 | $0.94 | $0.96 | $0.95 |
| Q4 2027 | 14 | $0.99 | $1.02 | $1.00 |
| Q1 2028 | 11 | $0.97 | $1.00 | $0.99 |
| Q2 2028 | 8 | $1.00 | $1.03 | $1.02 |
| Q3 2028 | 8 | $1.03 | $1.06 | $1.04 |
| Q4 2028 | 15 | $1.10 | $1.13 | $1.11 |
Boston Scientific Corp. Earnings Date And Information
Boston Scientific Corp. last posted its earnings results on Wednesday, April 22nd, 2026. The company reported $0.8 earnings per share for the quarter, topping analysts' consensus estimates of $0.788 by $0.012. The company had revenue of 5.20 B for the quarter and had revenue of 20.07 B for the year. Boston Scientific Corp. has generated $2 earnings per share over the last year ($1.94 diluted earnings per share) and currently has a price-to-earnings ratio of 22.18. Boston Scientific Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Boston Scientific Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2026 | Q1 2026 | N/A | $0.90 | N/A | $5.17 B | $5.20 B |
| 02/17/2026 | Q4 2025 | N/A | $0.45 | N/A | $5.28 B | $5.29 B |
| 11/03/2025 | Q3 2025 | N/A | $0.51 | N/A | $4.97 B | $5.07 B |
| 08/01/2025 | Q2 2025 | N/A | $0.54 | N/A | $4.89 B | $5.06 B |
| 05/01/2025 | Q1 2025 | N/A | $0.46 | N/A | $4.57 B | $4.66 B |
| 02/18/2025 | Q4 2024 | N/A | $0.38 | N/A | $4.42 B | $4.56 B |
| 11/01/2024 | Q3 2024 | N/A | $0.32 | N/A | $4.04 B | $4.21 B |
| 08/01/2024 | Q2 2024 | N/A | $0.22 | N/A | $4.03 B | $4.12 B |
| 05/01/2024 | Q1 2024 | N/A | $0.34 | N/A | $3.68 B | $3.86 B |
| 02/21/2024 | Q4 2023 | N/A | $0.34 | N/A | N/A | $3.73 B |
| 11/01/2023 | Q3 2023 | N/A | $0.34 | N/A | N/A | $3.53 B |
| 08/03/2023 | Q2 2023 | N/A | $0.18 | N/A | N/A | $3.60 B |
| 05/04/2023 | Q1 2023 | N/A | $0.21 | N/A | N/A | $3.39 B |
| 02/23/2023 | Q4 2022 | N/A | $0.09 | N/A | N/A | $3.24 B |
| 11/03/2022 | Q3 2022 | N/A | $0.12 | N/A | N/A | $3.17 B |
| 08/04/2022 | Q2 2022 | N/A | $0.17 | N/A | N/A | $3.24 B |
| 05/05/2022 | Q1 2022 | N/A | $0.07 | N/A | N/A | $3.03 B |
| 02/23/2022 | Q4 2021 | N/A | $0.06 | N/A | N/A | $3.13 B |
| 11/04/2021 | Q3 2021 | N/A | $0.28 | N/A | N/A | $2.93 B |
| 08/06/2021 | Q2 2021 | N/A | $0.12 | N/A | N/A | $3.08 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Boston Scientific Corp. Earnings: FAQ's
In the previous quarter, Boston Scientific Corp. (:BSX) reported $0.8 earnings per share (EPS) to beat the analysts' consensus estimate of $0.788 by $0.012.
The conference call for Boston Scientific Corp.'s latest earnings report can be listened to online.
The conference call transcript for Boston Scientific Corp.'s latest earnings report can be read online.
Boston Scientific Corp. (:BSX) has a recorded annual revenue of $20.07 B.
Boston Scientific Corp. (:BSX) has a recorded net income of $2.89 B.Boston Scientific Corp. has generated $1.96 earnings per share over the last four quarters.
Boston Scientific Corp. (:BSX) has a price-to-earnings ratio of 22.18 and price/earnings-to-growth ratio is 0.3.